For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...

Bala V Sathyanarayanan serves as EVP & CHRO at Greif, Inc (NYSE: GEF) & Chairman of the Board of Directors at Balmer Lawrie - Van Leer Ltd. Organizations face unprecedented opportunities and ...

For an organization to thrive, it must be committed to continual, positive change. The secret to this level of growth is implementing an organizational development (OD) strategy at your company.

I introduced an organizational process structure a few years ago that I titled the Rho (P) Organization. The concept was comprised of four key elements: Organizational Planning, Project Management, ...

The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...